Longevity & Performance

Biological age reflects how well your cells and organs are functioning, which can be years younger or older than your calendar age. It's typically measured using epigenetic clocks, which analyse DNA methylation patterns to estimate how fast the body is ageing at a cellular level. Unlike genetic risk, which is fixed, biological age can shift with the right interventions — making it a useful marker for tracking progress, not just a diagnostic snapshot. At Elysium, biological age is one of several markers used to build and monitor your personalised longevity strategy.

Chronic low-grade inflammation is one of the most consistently identified drivers of biological ageing. Apheresis⁺ addresses this directly, filtering inflammatory mediators, lipids, and other circulating burden from the blood. A 2022 clinical study tracked 10 specific protein biomarkers before and after rounds of therapeutic plasma exchange, finding reduced cellular senescence and lower DNA damage in blood cells afterward — early, promising evidence at the biomarker level. At Elysium Institut, Apheresis⁺ is used where clinically appropriate, alongside diagnostics, oxygenation, and recovery therapies.

Safety depends on the therapy and the supervision behind it. In a multinational registry covering over 50,000 apheresis procedures across 7,142 patients, adverse events were mild in 2.4% of cases, moderate in 3%, and severe in only 0.4% — typically related to venous access, device handling, or transient hypotension. A separate registry tracking lipoprotein apheresis specifically recorded adverse events in 4.44% of 4,667 treatments across 930 patients, with the vast majority resolving without complication. At Elysium, every treatment is preceded by medical screening and delivered under continuous physician supervision.

No two biological profiles age the same way, so we don't offer one-size-fits-all protocols. Every program begins with advanced diagnostics to identify your specific biological priorities, followed by a personalised strategy aligned to your goals and lifestyle. Interventions — including Apheresis⁺ where appropriate — are then selected and adjusted continuously as your biology and results evolve. The plan reflects what your diagnostics show, not a template.

Yes. Confidentiality is both structural to our concierge model and a legal obligation. Swiss healthcare providers are bound by the Federal Act on Data Protection, which treats health information as a sensitive category requiring stricter safeguards against unauthorised access or misuse. In practice, this means your consultations, diagnostics, and records are handled with full discretion, appointments are individual, and care is delivered in private treatment suites.

Plasma exchange replaces a volume of plasma with a clean substitute. A 2022 clinical study (GeroScience) found repeated exchange lowered several biological-age biomarkers and reduced DNA-damage/senescence markers — promising but early, biomarker-level evidence, not proof of longer life. For Long COVID, the best controlled trial showed no symptomatic benefit, though safe. We position it transparently: established for defined indications, investigational for anti-ageing.

A typical apheresis/lipid-apheresis session lasts ~2 hours as an outpatient. For conditions like elevated Lp(a) it is commonly weekly or at individually set intervals, since removed lipoproteins re-accumulate. Frequency and protocol are tailored under physician supervision.

On the shore of Lake Zurich, Switzerland. Contact concierge at reception@elysiuminstitut.ch / +41 44 244 83 83, or the Request-a-Consultation form.